Altria-backed cannabis producer Cronos explores sale
Reuters
Published Jul 06, 2023 02:50PM ET
Updated Jul 07, 2023 11:46AM ET
By Anirban Sen
NEW YORK (Reuters) -Cronos Group Inc, the Canadian cannabis producer backed by cigarette maker Altria Group (NYSE:MO) Inc, confirmed on Thursday it is in talks with potential buyers to explore a sale of the company, after Reuters reported on the talks.
Cronos is working with a financial adviser to handle expressions of interest in a deal from other companies, including U.S.-based peer Curaleaf Holdings (OTC:CURLF) Inc, according to people familiar with the matter.
The sources requested anonymity because the discussions are confidential, and they cautioned that no transaction is certain.
In a statement, Cronos said it "is in the initial stages of reviewing these indications of interest."
Curaleaf declined to comment. Spokespeople for Altria did not immediately respond to a request for comment.
Shares of Cronos jumped as much as 25% in Toronto on the news, before giving back all gains and closing lower at $1.88, giving it a market value of C$954.62 million ($714.38 million). So far this year, the shares have lost a quarter of their value.
The future of the cannabis industry is uncertain as more favorable regulatory regimes in North America have fueled fierce competition among more companies.
The recreational use of cannabis is now legal in 23 U.S. states. Growing and selling marijuana remains illegal under U.S. federal law, although President Joe Biden's administration has signaled it is seeking a review on how the drug is classified.
U.S. lawmakers have also been considering making it easier for the industry to access banking services.
For the first quarter, Cronos posted a net loss of $19.3 million, compared with a loss of $32.7 million a year ago. Net revenue declined 20% to $20.1 million. Cronos has total cash, including short-term investments, of about $836.43 million, according to its first-quarter report.
Altria, which holds a 41% stake in Cronos, invested $1.8 billion in the company in 2019.
Get The News You Want
($1 = 1.3363 Canadian dollars)
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.